As part of the Future Research Assessment Programme, the four UK higher education funding bodies (Research England, Scottish Funding Council, Higher Education Funding Council for Wales, and Department for the Economy, Northern Ireland) seek to understand the impact of the REF 2021 on the research community.
The real-time REF review report (pdf) collected attitudes to the REF as UK institutions prepared their submissions. Now the funding bodies aim to find out to what extent the views identified in the report are representative of the wider UK research community.
Although the REF is not an assessment of individuals, this survey looks at how unit-level assessment impacts individual researchers. Responses to this consultation are invited from any individuals with an interest in REF 2021. Only responses received through the online form will be reviewed and included in our analysis. All responses made through the online form by the deadline will be considered.
The survey will remain open until noon on 26 January 2022.
Take part in the survey here: Individual feedback survey on the REF 2021 | Jisc
BU REF 2021 Code of Practice – staff feedback exercise










NIHR Insight South West Central Conference 2026 at Bournemouth University
BU PhD student presented at World Safety Conference in South Africa
National Research Supervision Recognition: Apply Now & Join the Supporting Workshop on 16 September
3C Event: ECR Network Café – Wednesday 16 September 2-3pm
BU geography student’s undergraduate dissertation published in international journal
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease